Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.65% | 88.15 | 1.3% | $855.06m | |
| AMGN | Amgen Inc. | -2.71% | 186.70 | 1.2% | $536.92m | |
| BIIB | Biogen Inc. | -4.48% | 216.71 | 1.3% | $511.45m | |
| ONCE | Spark Therapeutics, Inc. | -0.24% | 113.00 | 11.2% | $460.68m | |
| GILD | Gilead Sciences, Inc. | -1.77% | 63.77 | 0.9% | $455.57m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.68% | 391.80 | 2.6% | $275.42m | |
| ILMN | Illumina, Inc. | -3.26% | 308.79 | 3.5% | $273.28m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.56% | 181.53 | 1.9% | $235.95m | |
| BPTH | Bio-Path Holdings, Inc. | 18.94% | 21.98 | 190.1% | $220.64m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.47% | 122.26 | 15.4% | $207.36m | |
| EXAS | Exact Sciences Corporation | -3.28% | 89.00 | 25.3% | $185.14m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.98% | 130.21 | 2.0% | $179.59m | |
| A | Agilent Technologies, Inc. | -3.68% | 78.98 | 1.6% | $135.89m | |
| IONS | Ionis Pharmaceuticals, Inc. | -1.99% | 78.90 | 8.3% | $104.26m | |
| INCY | Incyte Corporation | -2.00% | 85.34 | 2.5% | $93.76m |
Company Profile
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.